India’s pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also expected to expand by 9-11 percent as prescription demand rises. Strong cash generation and healthy balance sheets will help maintain credit profiles despite margin pressures. Cost inflation from raw materials and freight may compress operating margins by 150-200 basis points.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.